NexLife review

What it is

NexLife is run by Nexlife Inc., a patient-management platform at 260 Newport Center Drive in Newport Beach, California. Its physicians practice as Nexlife Medical Group, and the medication comes from independent U.S.-licensed compounding pharmacies and FDA-registered outsourcing facilities; NexLife says it doesn't make, compound, test, label or dispense drugs itself. The site displays a numbered LegitScript certification seal. Its weight-loss program covers compounded semaglutide and compounded tirzepatide, and every plan adds what it calls Care 360: a personalized GLP-1-focused nutrition plan, a one-on-one call with a certified wellness coach, progress-tracking tools and around-the-clock customer support from staff, with physician access during clinical hours. It's cash-pay only: it doesn't take commercial insurance and isn't enrolled with Medicare or Medicaid, but FSA and HSA cards, Klarna and Afterpay are accepted. Care runs entirely online for adults in eligible states.

How it works

You start with a short online assessment of your health history and goals, then a U.S.-licensed provider from Nexlife Medical Group reviews it and decides whether compounded semaglutide or tirzepatide is appropriate. No in-person visit is needed, and you can call or text before signing up if you want to talk first. If you're prescribed, the pharmacy ships the medication each month, typically within a few business days, as a once-weekly injection you give yourself at home with written instructions. From there your provider monitors progress and adjusts your dose, and the coaching and support team stays available through the patient portal. The terms note that, since the FDA declared the semaglutide and tirzepatide shortages resolved, compounded versions are prescribed only where a provider documents a medical need.

Pricing transparency

On the monthly plan, compounded semaglutide is $139 a month and compounded tirzepatide $169 a month, all-inclusive and the same at every dose. Longer plans cut the monthly price: semaglutide is $132 on a three-month plan, $125 on six months and $119 on twelve, and tirzepatide $159, $149 and $139. The longer plans start only if you're prescribed, and unshipped months are refunded if treatment stops. Any authorization charge is refunded in full if you aren't prescribed or don't go ahead. Plans renew automatically until you cancel, by call, text, email or portal message, and cancellations take effect after 30 days, so you may be charged for one more shipment unless the medical group approves stopping sooner for a medical reason. A results-based refund applies to members who enrolled from January 2026, stay at least 180 days with no gaps, log their weight every two weeks, started at a BMI of 30 or more and lose less than 5% of their weight: they can claim back program fees, but not medication costs. The site's own example puts that at about $250 of $834 spent over six months on the $139 plan.

Branded vs compounded

The options are compounded semaglutide and compounded tirzepatide, prepared on a patient-specific basis by U.S.-licensed compounding pharmacies. NexLife states clearly that compounded medications aren't FDA-approved or evaluated for safety, effectiveness or quality, that its semaglutide isn't Ozempic or Wegovy and its tirzepatide isn't Mounjaro or Zepbound, and that it has no tie to Novo Nordisk or Eli Lilly. Brand-name GLP-1s aren't offered. In June 2026 the FDA sent Nexlife Inc. a warning letter after reviewing its website in March 2026. The agency's objection was that pictured product labels carried the Nexlife name, suggesting Nexlife compounded the drugs when it doesn't, which made the products misbranded; the letter asked it to identify the companies that actually produce them.

Pros and watch-outs

The evidence behind what NexLife prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How NexLife compares

A few alternatives worth a look, depending on what you’re optimizing for.

• WellMedRx

  Compounded GLP-1s by injection or tablet, with a named clinician network and pharmacy

  See WellMedRx →
• Enhance MD

  Lab-guided treatment under ongoing physician oversight

  See Enhance MD →
• MyFastRx

  Cash buyers who want a compounded GLP-1 one month at a time, with no recurring charge and a flat price at every dose

  See MyFastRx →

More GLP-1 telehealth reviews: Mondae · NEUVÉ Health · Nex Gen Health Rx · Nova · Oria Meds · RENN Health